Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2005-11-29
2005-11-29
Chernyshev, Olgan N. (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S141100, C424S172100, C424S001410, C530S387100, C435S337000
Reexamination Certificate
active
06969516
ABSTRACT:
A method is described comprising the combined administration of a novel composition comprising serum complement proteins with complement-fixing antibodies to induce transient disruption of myelin and/or demyelination. The antibodies specifically bind to one or more epitopes of myelin, and complement proteins. A method is also described for promoting regrowth, repair, and regeneration of neurons in a mammalian subject. The methods can be used following immediate or chronic injury.
REFERENCES:
Barinaga, M., 1994, Science, 264, pp. 772-774.
Bregman et al., “Recovery from Spinal Cord Injury Mediated by Antibodies to Neurite Growth Inhibitors”,Nature, 378:498-501 (1995).
Caroni et al., “Antibody Against Myelin-Associated Inhibitor of Neurite Growth Neutralizes Nonpermissive Substrate Properties of CNS White Matter,”Neuron, 1: 85-96 (1988).
Dubois-Dalco et al., “Action of Anti-Cerebroside Sera on Myelinated Nervous Tissue Cultures”,Path. Europ., 5(3): 331-347 (1970).
Dyer et al., “Glycolipids and Transmembrane signaling: Antibodies to Galactocerebroside Cause an Influx of Calcium in Oligondendrocytes”,J. Cell Biol., 111:625-633 (1990).
Dyer et al., “Antibodies to Myelin/Oligodendrocyte-Specific Protein and Myelin/Oligodendrocyte Glycoprotein Signal Distinct Changes in the Organization of Cultured Oligondendroglial Membrane Sheets,”J. of Neurochemistry, 62:777-787 (1994).
Keirstead et al., “Identification of post-mitotic oligodendrocytes incapable of remyelinatio within the demyelinated adult spinal cord,”Journal of Neuropathy&Experimental Neurology, 56(11):1191-1201 (Nov. 1997).
Linington et al., “Induction of Persistently Demyelinated Lesions In the Rat Following the Repeated Adoptive Transfer of Encephalitogenic T Cells and Demyelinating Antibody,”J. Neuroimmunol, 40(2-3):219-224 (1992).
Meeson, A.P. et al., “The Distribution of Inflammatory Demyelinated Lesions In the Central Nervous System of Rats With Antibody-Augmented Demyelinating Experimental Allergic Encephalomyelitis,”Exp. Neurol, 129(2):299-310 (1994).
Keirstead et al., “In Vivo Immunological Suppression of Spinal Cord Myelin Development,”Brains Res. Bull., 44:727-734 (1997).
Dyer Jason K.
Keirstead Hans S.
Steeves John D.
Chernyshev Olgan N.
DLA Piper Rudnick Gray Cary US LLP
MBM & Co.
LandOfFree
Immunological compositions and methods of use to transiently... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunological compositions and methods of use to transiently..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunological compositions and methods of use to transiently... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3518511